Carolyn Bertozzi

Carolyn Bertozzi

Directeur/Membre du Conseil chez ELI LILLY AND COMPANY

Fortune : 3 M $ au 31/07/2026

59 ans
Health Technology
Commercial Services
Consumer Services

Profil

Dr. Carolyn R.
Bertozzi
is an Independent Director at Eli Lilly & Co., an Independent Director at OmniAb, Inc., an Independent Director at OmniAb Operations, Inc., a Member at Accademia Nazionale dei Lincei, a Member at American Academy of Arts & Sciences, a Member at American Chemical Society, a Member at American Society for Biochemistry & Molecular Biology, Inc., a Member at National Academy of Inventors, a Member at National Academy of Medicine (United States), a Member at National Academy of Sciences, a Member at The Royal Society, a Professor at Howard Hughes Medical Institute, Inc. and a Professor at Stanford University.
She is on the Board of Directors at Eli Lilly & Co., OmniAb, Inc., Stanford Chem-H, Grace Science Foundation, Xaira Therapeutics, Inc. and OmniAb Operations, Inc. Dr. Bertozzi was previously employed as a Co-Founder by TwoStep Therapeutics, Inc., an Independent Director by Alnylam Pharmaceuticals, Inc., a Co-Founder by Valora Therapeutics, Inc., a Founder by Lycia Therapeutics, Inc., a Co-Founder by Venn Biosciences Corp., a Chairman by Enable Biosciences, Inc., a Co-Founder by Palleon Pharmaceuticals, Inc., a Co-Founder by Redwood Bioscience, Inc., a Professor by University of California, Berkeley, a Co-Founder by Firefly Bio, Inc., and a Director-Molecular Foundry by Lawrence Berkeley National Laboratory.
She also served on the board at Catalent, Inc., Molecular Foundry and The Broad Institute, Inc. She received her undergraduate degree from Harvard University and a doctorate degree from the University of California, Berkeley.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
25/02/2026 2 000 ( 0 % ) 2 M $ 31/07/2026
17/06/2026 113 308 ( 0,08 % ) 224 350 $ 31/07/2026
08/05/2025 775 ( 0 % ) 159 278 $ 31/07/2026

Postes actifs de Carolyn Bertozzi

SociétésPosteDébut
OMNIAB, INC. Directeur/Membre du Conseil 01/11/2022
ELI LILLY AND COMPANY Directeur/Membre du Conseil 08/12/2025
Stanford Chem-H
Directeur/Membre du Conseil 01/01/2021
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
Directeur/Membre du Conseil -
Corporate Officer/Principal -
Directeur/Membre du Conseil -

Anciens postes connus de Carolyn Bertozzi

SociétésPosteFin
░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░ ░░░░░ ░░░ ░░░░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░ ░░ ░░░░░░░░░░░ ░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░ ░░░░ ░░░░░░░░░ -
Voir l'expérience en détail de Carolyn Bertozzi

Formation de Carolyn Bertozzi

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

87

Relations au 1er degré

28

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées28

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Commercial Services

Miscellaneous

Miscellaneous

Consumer Services

Commercial Services

Commercial Services

Commercial Services

Commercial Services

Commercial Services

Health Technology

Commercial Services

Health Technology

Health Technology

Commercial Services

Commercial Services

Health Technology

Stanford Chem-H

Health Technology

Health Services

Health Technology

Commercial Services

Molecular Foundry

Health Technology

  1. Bourse
  2. Insiders
  3. Carolyn Bertozzi
🔇